A trial combining treatments. Not really exciting but may prove useful.
Two MS drugs better than one?
Mon 17 Apr 2006 12:01 PM CST
WASHINGTON DC (myDNA News)
Enrollment has begun for CombiRx, a clinical trial that will examine the effectiveness of two medications taken in combination to treat relapsing-remitting multiple sclerosis (MS). The U.S. Food and Drug Administration (FDA) has already approved both drugs.
Sponsored by the Bethesda, Md.-based National Institutes of Health, the ...